{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:08:55Z","timestamp":1789427335169,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005554","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000}}],"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1-R01-AI107731-01"],"award-info":[{"award-number":["1-R01-AI107731-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI109784-01"],"award-info":[{"award-number":["U19 AI109784-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["PO1 AI106695"],"award-info":[{"award-number":["PO1 AI106695"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RO1 AI099631"],"award-info":[{"award-number":["RO1 AI099631"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pediatric Dengue Vaccine Initiative","award":["VE-1"],"award-info":[{"award-number":["VE-1"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005554","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T14:01:38Z","timestamp":1494856898000},"page":"e0005554","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Dissecting the human serum antibody response to secondary dengue virus infections"],"prefix":"10.1371","volume":"11","author":[{"given":"Bhumi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Miley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magelda","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3317-5950","authenticated-orcid":true,"given":"Aravinda M.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"ref1","first-page":"3087","article-title":"Fields virology","volume":"xix","author":"BN Fields","year":"2001"},{"issue":"7446","key":"ref2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"S Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref3","first-page":"485","article-title":"Dengue","volume":"xx","author":"SB Halstead","year":"2008"},{"issue":"15","key":"ref4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"CP Simmons","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"16055","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue infection","volume":"2","author":"MG Guzman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/vim.2007.0050","article-title":"Antibody to Dengue 1 Detected More Than 60 Years after Infection","volume":"20","author":"A Imrie","year":"2007","journal-title":"Viral immunology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"BR Murphy","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"19","key":"ref8","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"R de Alwis","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"G Fibriansah","year":"2014","journal-title":"EMBO Molecular Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"G Fibriansah","year":"2015","journal-title":"Nat Commun"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1128\/JVI.00247-14","article-title":"Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones","volume":"88","author":"SA Smith","year":"2014","journal-title":"J Virol"},{"issue":"139","key":"ref12","first-page":"139ra83-ra83","article-title":"The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody","volume":"4","author":"EP Teoh","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"4839","key":"ref13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of Dengue: Challenges to Molecular Biology","volume":"239","author":"SB Halstead","year":"1988","journal-title":"Science"},{"key":"ref14","first-page":"141","article-title":"Advances in Virus Research","volume":"Volume 59","author":"JT Roehrig","year":"2003"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of Dengue Virus: Implications for Flavivirus Organization, Maturation, and Fusion","volume":"108","author":"RJ Kuhn","year":"2002","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-422X-7-28","article-title":"Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient","volume":"7","author":"JS Schieffelin","year":"2010","journal-title":"Virology Journal"},{"issue":"13","key":"ref17","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II","volume":"82","author":"C-Y Lai","year":"2008","journal-title":"Journal of Virology"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"M Beltramello","year":"2010","journal-title":"Cell host & microbe"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/648592","article-title":"Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua","volume":"201","author":"A Balmaseda","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/aje\/kwp092","article-title":"The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases","volume":"170","author":"G Kuan","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"LC Katzelnick","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","article-title":"Symptomatic versus inapparent outcome in secondary dengue virus infections is influenced by the time interval between infections and study year","volume":"7","author":"M Montoya","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","article-title":"Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody","volume":"392","author":"WMPB Wahala","year":"2009","journal-title":"Virology"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization","volume":"45","author":"AA Kraus","year":"2007","journal-title":"Journal of Clinical Microbiology"},{"key":"ref25","first-page":"27","article-title":"Dengue Methods and Protocols Preface","volume":"1138","author":"R Padmanabhan","year":"2014","journal-title":"Dengue: Methods and Protocols"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/jiu481","article-title":"Preexisting Neutralizing Antibody Responses Distinguish Clinically Inapparent and Apparent Dengue Virus Infections in a Sri Lankan Pediatric Cohort","volume":"211","author":"KS Corbett","year":"2015","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"W Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"key":"ref28","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","author":"A Rouvinski","year":"2015","journal-title":"Nature"},{"issue":"23","key":"ref29","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1128\/JVI.00871-13","article-title":"High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection","volume":"87","author":"W-Y Tsai","year":"2013","journal-title":"Journal of Virology"},{"issue":"14","key":"ref30","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.00273-15","article-title":"Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies","volume":"89","author":"WY Tsai","year":"2015","journal-title":"J Virol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"e1568","DOI":"10.1371\/journal.pntd.0001568","article-title":"Dominant Cross-Reactive B Cell Response during Secondary Acute Dengue Virus Infection in Humans","volume":"6","author":"S Zompi","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcv.2007.04.005","article-title":"Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection","volume":"39","author":"VA de Souza","year":"2007","journal-title":"J Clin Virol"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JCM.43.6.2793-2797.2005","article-title":"Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample","volume":"43","author":"S Matheus","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"9853","key":"ref34","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"A Sabchareon","year":"2012","journal-title":"The Lancet"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model","volume":"80","author":"B Guy","year":"2009","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"9951","key":"ref36","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"MR Capeding","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"L Villar","year":"2015","journal-title":"The New England journal of medicine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005554","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T13:32:22Z","timestamp":1569331942000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005554"}},"subtitle":[],"editor":[{"given":"Amy C","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005554","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005554","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}